文献速递静脉血栓栓塞

合并深静脉血栓对急性肺栓塞结局的影响:PERT联盟登记研究

Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-04-13

基于PERT联盟登记中7346例以中高危为主的急性肺栓塞患者,69%合并深静脉血栓。合并DVT与更高级别风险分层及更多使用先进治疗相关,但校正先进治疗后未增加住院、30天或1年死亡率。

要点

  • 急性肺栓塞合并DVT常见,占69%,且更多归为中高危分层。
  • 合并DVT显著增加接受先进治疗(尤其导管定向治疗)的 odds。
  • 校正先进治疗后,合并近端DVT未增加住院、30天或1年死亡率。

核心结论

  • 在以中高危为主的急性肺栓塞人群中,合并DVT常见且与更严重表现和更多先进治疗使用相关,但不增加短期或长期死亡率。

研究设计与样本

  • 基于PERT联盟登记数据的回顾性队列研究,纳入7346例以急性中危和高危为主的肺栓塞患者。

主要发现

  • 7346例急性PE中5076例(69%)合并DVT。
  • 合并DVT者更多为中高危(59.31% vs 51.9%,P<.001)和中低危(19.4% vs 17.7%,P<.001)。
  • 合并DVT与接受先进治疗的 odds 升高相关(OR 2.49;95%CI 2.14-2.81),尤其导管定向治疗(OR 2.44;95%CI 2.12-2.83)。
  • 中高危组中DVT与先进治疗的关联最强(OR 2.67;95%CI 2.25-3.18)。
  • 校正先进治疗后,近端DVT与住院死亡率(OR 0.87;95%CI 0.69-1.09)、30天死亡率(OR 0.96;95%CI 0.77-1.20)、1年死亡率(OR 0.87;95%CI 0.73-1.03)及ICU入住(OR 1.05;95%CI 0.93-1.20)无显著相关。

临床怎么用

  • 合并DVT的急性PE患者应视为更高风险表型,可能更需评估先进治疗适应证。
  • 不应仅因合并近端DVT而预期短期或长期死亡率升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Studies have reported conflicting data regarding the prognostic significance of concomitant deep vein thrombosis (DVT) in acute pulmonary embolism (PE). Understanding the potential differences between PE with and without DVT is crucial for optimizing strategies. METHODS: Using data from The Pulmonary Embolism Response Teams Consortium Registry, this study examined the association between concomitant DVT and clinical outcomes in patients with predominantly acute intermediate- and high-risk PE. A secondary aim was to assess the impact of DVT on treatment selection, particularly the use of advanced therapies. RESULTS: Among 7346 patients with acute PE, 5076 (69%) had concomitant DVT. Patients with DVT were more frequently classified as intermediate-risk compared with patients without DVT, including intermediate-high (59.31% vs 51.9%; P < .001) and intermediate-low risk PE (19.4% vs 17.7%; P < .001). The presence of DVT was significantly associated with higher odds of receiving advanced therapies (odds ratio [OR], 2.49; 95% confidence interval [CI], 2.14-2.81), particularly catheter-directed therapy (OR, 2.44; 95% CI, 2.12-2.83), with the strongest association observed in the intermediate- to high-risk group (OR, 2.67; 95% CI, 2.25-3.18). Concomitant proximal DVT was not associated with increased in-hospital mortality (OR, 0.87; 95% CI, 0.69-1.09), 30-day mortality (OR, 0.96; 95% CI, 0.77-1.20), 1-year mortality (OR, 0.87; 95% CI, 0.73-1.03), or intensive care unit admission (OR, 1.05; 95% CI, 0.93-1.20), after adjustment for advanced therapy use. CONCLUSIONS: In this large contemporary cohort of predominantly intermediate- and high-risk PE, concomitant DVT was common and associated with more severe presentation and greater use of advanced therapies, but not with higher short- or long-term mortality.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Lio KU, Jaber WA, Sethi S, et al. Impact of concomitant deep vein thrombosis on outcomes of acute pulmonary embolism: Insights from the PERT consortium registry. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41985839. doi:10.1016/j.jvsv.2026.102499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。